UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.14+0.97 (+3.02%)
At close: 04:00PM EDT
34.00 +0.86 (+2.60%)
After hours: 07:54PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts14141515
Avg. Estimate-1.13-1.14-4.71-4.68
Low estimate-1.33-1.32-5.15-5.65
High estimate-0.91-0.88-3.87-3.3
Year ago EPS-1.08-1.22-1.72-4.71
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts14131414
Avg. Estimate14.18M13.97M51.35M51.92M
Low estimateN/AN/A7.4MN/A
High estimate24.2M24.2M80.01M110M
Year ago sales20.12MN/A377.71M51.35M
Sales growth (year/est)-29.50%N/A-86.40%1.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.42-1.36-1.01-1.42
Actual EPS-1.08-1.221.73-1.21
Difference0.340.142.740.21
Surprise %23.90%10.30%271.30%14.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.13-1.14-4.71-4.68
7 days ago-1.14-1.16-4.75-4.77
30 days ago-1.14-1.15-4.75-4.75
60 days ago-1.14-1.15-4.75-4.76
90 days ago-1.38-1.35-5.38-5.07
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBEAMIndustrySector(s)S&P 500
Current qtr.-4.60%N/AN/AN/A
Next qtr.6.60%N/AN/AN/A
Current year-173.80%N/AN/AN/A
Next year0.60%N/AN/AN/A
Next 5 years (per annum)-3.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A